|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Talyst Raises $8M, MDRNA Sells Stock for $10.5M, Sonosite Buys CardioDynamics & More Seattle-Area Deals News
|
Eric Hal Schwartz |
06/16/09 |
Seattle
|
|
Dendreon Resists Urge to Sell Out, NanoString Nabs $30M, VC Firm Cashes Out on OncoGenex, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
06/11/09 |
Seattle
|
|
MDRNA Raises $10.5M
|
Luke Timmerman |
06/10/09 |
Seattle
|
|
MDRNA Obtains $10,500,000 New Funding
|
VentureDeal |
06/10/09 |
Seattle
|
|
MDRNA Nasal Spray Gets FDA Nod
|
Luke Timmerman |
06/09/09 |
Seattle
|
|
Vulcan’s Biotech Windfall, Tekmira Tackles RNAi Delivery, The $1,000 Genome Debate, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/28/09 |
Seattle
|
|
MDRNA Shrinks Board of Directors
|
Luke Timmerman |
05/21/09 |
Seattle
|
|
Swype Scores $1.3M, Onehub Raises $600K, Genzyme Comes to Town, & More Seattle-Area Deals News
|
Gregory T. Huang |
04/07/09 |
Seattle
|
|
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/02/09 |
Seattle
|
|
MDRNA Sells Osteoporosis Drug
|
Luke Timmerman |
04/01/09 |
Seattle
|
|
Obama Stimulates UW, Public Biotechs Run Low on Cash, Healionics Ships Glaucoma Product & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/26/09 |
Seattle
|
|
The Northwest Biotech Survival Index 2: Companies Scraping By in Downturn
|
Luke Timmerman |
03/25/09 |
Seattle
|
|
Intellectual Ventures Inks India Deal, Ontela Teams with T-Mobile, MDRNA Nabs $7.25M, & More Seattle-Area Deals News
|
Gregory T. Huang |
03/24/09 |
Seattle
|
|
MDRNA Nabs $7.25M From Novartis
|
Luke Timmerman |
03/23/09 |
Seattle
|
|
MDRNA Secures $7,250,000 Series D Financing Round
|
VentureDeal |
03/23/09 |
Seattle
|
|
PivotLink Lands $10M, Founder’s Funds Frugal, Earth Class Mail Signs Swiss Post, & More Seattle-Area Deals News
|
Gregory T. Huang |
02/17/09 |
Seattle
|
|
MDRNA Cuts Deal With Roche
|
Luke Timmerman |
02/13/09 |
Seattle
|
|
Sticking it to the VC Man: Johnny Stine Builds Biotech Startup on a Shoestring
|
Luke Timmerman |
02/06/09 |
Seattle
|
|
Pathway Medical Gets Traction, Ekos Raises $12.5M, ZymoGenetics Sales Boss Departs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
02/05/09 |
Seattle
|
|
MDRNA Gets $1M Milestone
|
Luke Timmerman |
02/03/09 |
Seattle
|
|
Seattle Genetics Raises Dough, Trubion Feels Fallout of Pfizer Deal, Novo Sets Up Shop, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
01/29/09 |
Seattle
|
|
MDRNA Cuts Executive Pay, Freezes Salaries as Cash Runs Out
|
Luke Timmerman |
01/23/09 |
Seattle
|
|
MDRNA Gets Tentative FDA Approval
|
Luke Timmerman |
12/15/08 |
Seattle
|
|
Biotech Survival Index: Cash Running Low at Seattle Life Sciences Companies
|
Luke Timmerman |
11/13/08 |
Seattle
|
|
Alnylam–Isis Venture Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments
|
Luke Timmerman |
10/24/08 |
San Diego
|
|
MDRNA Cuts 23 Jobs, Mostly in Nasal Delivery Business
|
Luke Timmerman |
08/05/08 |
Seattle
|
|
Page 2 of
2 |
« previous page |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.